ArticleBMC cancer2012

Prognostic significance of anti-p53 and anti-KRas circulating antibodies in esophageal cancer patients treated with chemoradiotherapy.

Pierre Blanchard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.